1.Treatment of hypertension in diabetes mellitus.
Journal of the Korean Academy of Family Medicine 2001;22(5):603-610
No abstract available.
Diabetes Mellitus*
;
Hypertension*
2.Development of guide to clinical performance and basic clinical skills for medical students.
Hyerin ROH ; Keunmi LEE ; Eunkyung EO ; Young Sun HONG ; Hakseung LEE ; Byung Woo JANG ; Byoung Doo RHEE
Korean Journal of Medical Education 2015;27(4):309-319
The aim of this report was to discuss the development and content of a guide on clinical performance and basic clinical skills for medical students. We published the first edition of this guide in 2010 and will publish the second edition in 2016. Initially, we took a survey on important clinical presentations and fundamental clinical and technical skills in 41 medical schools in Korea. Ultimately, we chose 80 core clinical presentations and 56 clinical skills. In the guide to basic clinical skills, we described the physical examination and technical skills according to the preprocedural preparation, procedure, and postprocedural process. In the guide on clinical performance, we reviewed patient encounters-from history taking and the physical examination to patient education. We included communication skills, principles of patient safety, and clinical reasoning schemes into the guides. In total, 43 academic faculty members helped develop the basic clinical skills guide, 75 participated in establishing the clinical performance guide, and 16 advisors from 14 medical specialty societies contributed to the guide. These guides can help medical students approach patients holistically and safely.
Clinical Competence/*standards
;
Educational Measurement/*methods
;
Humans
;
*Practice Guidelines as Topic
;
Republic of Korea
;
*Students, Medical
3.The Protective Effect of EGCG on INS-1 Cell in the Oxidative Stress and Mechanism.
Mi Kyung KIM ; Hye Sook JUNG ; Chang Shin YOON ; Min Jeong KWON ; Kyung Soo KOH ; Byung Doo RHEE ; Jeong Hyun PARK
Korean Diabetes Journal 2008;32(2):121-130
BACKGROUND: Oxidative stress is important in both diabetic complications and the development and the progression of type 2 diabetes via the effects on the pancreatic beta-cells. EGCG (epigallocatechin galleate), a major constituent of green tea, has been known to have beneficial effects on various diseases through the mechanisms of antioxidant and cell signaling modulation. But, very small numbers of studies were published about the direct effects of EGCG on the pancreatic beta cell lines. We performed this study to see the protective effect of EGCG on pancreatic beta cell line under H2O2 and the mechanisms of this phenomenon. METHODS: We used INS-1 cells and hydrogen peroxide as an oxidative stressor. Their viabilities were verified by MTT assay and FACS. The activity of glutathione peroxidase was assessed by total glutathione quantification kit. Western blot and semi-quantitative RT-PCR for the catalase, SOD (superoxide dismutase), PI3K and Akt were performed. Functional status of INS-1 cells was tested by GSIS (glucose stimulated insulin secretion). RESULTS: The biological effects of EGCG were different according to its concentrations. 10 micrometer EGCG effectively protected hydrogen peroxide induced damage in INS-1 cells. The expression and the activity of SOD, catalase and the glutathione peroxidase were significantly increased by EGCG. EGCG significantly increased PI3K and Akt activity and its effect was inhibited partially by wortmannin. GSIS was well preserved by EGCG. CONCLUSION: EGCG in low concentration effectively protected INS-1 cells from the oxidative stress through the activation of both antioxidant systems and anti-apoptosis signaling. Further studies will be necessary for the more detailed mechanisms and the clinical implications.
Androstadienes
;
Blotting, Western
;
Catalase
;
Diabetes Complications
;
Glutathione
;
Glutathione Peroxidase
;
Hydrogen Peroxide
;
Insulin
;
Insulin-Secreting Cells
;
Oxidative Stress
;
Tea
4.Clinical Evaluation of OneTouch Diabetes Management Software System in Patients with Type 2 Diabetes Mellitus.
Jung Min KIM ; Hey Jean LEE ; Keum Ok KIM ; Jong Chul WON ; Kyung Soo KO ; Byung Doo RHEE
Diabetes & Metabolism Journal 2016;40(2):129-139
BACKGROUND: OneTouch Diabetes Management Software (OTDMS) is an efficient way to track and monitor the blood glucose level. It is possible to download data from the OneTouch Ultra via the meter's data port, and to transform the numbers of the blood glucose level into a graph, a chart, or statistics. The objectives of this study were to evaluate whether the use of OTDMS in consultation hours would improve patients' knowledge of diabetes mellitus (DM), compliance, satisfaction with doctor and medical treatment, doctor-patient reliability, and glucose control. METHODS: All patients were randomized into either the OTDMS group using OneTouch Ultra or the control groups not using it. Both groups had conventional DM education and only the OTDMS group used data from OTDMS as explanation materials during consultation hours. At enrollment and after 6 months, we performed a questionnaire survey consisting of the diabetes knowledge test, items for compliance of treatment, patient's satisfaction, doctor-patient reliability, and glycosylated hemoglobin (HbA1c). RESULTS: We analyzed 6-month follow-up data from 92 patients (OTDMS 42 vs. control 50). Both groups showed significant improvements in HbA1c, diabetes knowledge, compliance, reliability, and satisfaction after 6 months. However, there were no significant differences between OTDMS and control groups overall. Only "weekly frequency of checking blood glucose level" of compliance and "trying to follow doctor's order" of reliability showed better results in the OTDMS group. CONCLUSION: Using the OTDMS system for explanation during consultation hours seems to be more helpful to improve patient's compliance and reliability, especially for checking blood glucose level and trying to follow the doctor's order.
Blood Glucose
;
Compliance
;
Diabetes Mellitus
;
Diabetes Mellitus, Type 2*
;
Disease Management
;
Education
;
Follow-Up Studies
;
Glucose
;
Hemoglobin A, Glycosylated
;
Humans
;
Self Care
5.Cloning of Novel Epidermal Growth Factor (EGF) Plasmid for Gene Therapy on Diabetic Foot Ulcer.
Hye Sook CHUNG ; Chang Shin YOON ; Min Jeong KWON ; Mi Kyung KIM ; Soon Hee LEE ; Kyung Soo KO ; Byung Doo RHEE ; Jeong Hyun PARK
Korean Diabetes Journal 2008;32(2):131-140
BACKGROUND: Epidermal Growth Factor (EGF) is one of the important growth factors involved in the epithelialization during cutaneous wound healing. Peptide EGF has been used for the treatment of diabetic foot ulcer. But the inferiority of cost-effectiveness and the inconvenience of daily application might have restricted its wide clinical usage. EGF gene therapy could dramatically improve the efficacy and inconvenience through long-term expression and bypassing the EGF degradation by hostile non-specific proteinases expressed in the wound bed. METHODS: EGF DNAs were amplified via PCR. For the more effective secretion from the transfected cell, we inserted furin cleavage site into EGF plasmids. The efficacy of novel plasmid pbeta-EGF was verified by transfection into the various animal cell lines, and the biologic potency of expressed EGF was confirmed via phosphorylation of PI3K and GSK3beta by Western blotting. RESULTS: We tested various kinds of human EGFs. One of the human EGF isoforms, EGF(828) including a membrane-anchoring domain was successfully released as the mature EGF protein in the cell culture media. Also EGF plasmid including furin cleavage site showed more than 2-fold increased EGF expression compared with the sequence without furin cleavage site. CONCLUSION: In conclusion, these findings suggest that mature EGF could be released easily out of cells by modifying EGF DNA sequence. Our novel EGF plasmid DNA could markedly increase the efficiency of non-viral gene therapy for diabetic foot ulcer.
Animals
;
Base Sequence
;
Cell Culture Techniques
;
Cell Line
;
Clone Cells
;
Cloning, Organism
;
Diabetes Mellitus
;
Diabetic Foot
;
DNA
;
Epidermal Growth Factor
;
Furin
;
Genetic Therapy
;
Glycogen Synthase Kinase 3
;
Humans
;
Intercellular Signaling Peptides and Proteins
;
Peptide Hydrolases
;
Phosphorylation
;
Plasmids
;
Polymerase Chain Reaction
;
Protein Isoforms
;
Transfection
;
Ulcer
;
Wound Healing
6.The effect of statins on HDL-cholesterol in type 2 diabetic patients.
Jong Ryul PARK ; Jang Hye JUNG ; Jung Youn MOON ; Ji Hye SUK ; Mi Kyung KIM ; Jeong Hyun PARK ; Byung Doo RHEE
Korean Journal of Medicine 2008;74(4):411-417
BACKGROUND/AIMS: Statins have been a mainstay of treatment for primary and secondary prevention of coronary heart disease through their beneficial effect on lipid profile. However, their effect on the HDL cholesterol level has been determined to be equivocal or unclear. This study sought to investigate HDL cholesterol response to statin treatment in type 2 diabetic patients. METHODS: We retrospectively assessed the effect of statins in 217 patients with type 2 diabetes and dyslipidemia through chart review. Patients who were using medications such as fibrates, niacin, or thiazolidinediones, or had a plasma creatinine concentration greater than 1.5 mg/dL, a fasting triglyceride level greater than 300 mg/dL, or chronic liver disease, were excluded from the study. RESULT: The mean level of LDL cholesterol was significantly decreased, and the percentage of patients who achieved the normal LDL cholesterol level was increased in this study. The mean HDL cholesterol level after statin treatment was decreased by 2.3%. The percent change of HDL cholesterol was affected by baseline HDL cholesterol level, percent change of total cholesterol, percent change of LDL cholesterol, and baseline total cholesterol level. When subjects were divided into quintiles according to baseline HDL cholesterol, HDL cholesterol level was found to be increased in the lowest two quintiles while it was decreased in the highest two quintiles. CONCLUSIONS: There were some patients whose HDL cholesterol level was decreased after statin treatment, depending on their baseline HDL cholesterol level. We think further study on the effect of statins on HDL level will be needed in the future.
Cholesterol
;
Cholesterol, HDL
;
Cholesterol, LDL
;
Coronary Disease
;
Creatinine
;
Dyslipidemias
;
Fasting
;
Fibric Acids
;
Humans
;
Liver Diseases
;
Niacin
;
Plasma
;
Retrospective Studies
;
Secondary Prevention
;
Thiazolidinediones
7.A Case of Central Diabetes Insipidus in a Patient with Systemic Lupus Erythematosus.
Ji Hyun KIM ; Young Jin NAM ; Mi Ran KWON ; Chan Hee LEE ; Seong Hoon HAN ; Won Do PARK ; Byung Doo RHEE ; Yun Woo LEE
The Journal of the Korean Rheumatism Association 2002;9(3):220-224
Central diabetes insipidus is caused by the insufficient secretion of vasopressin and has been reported in great variety of disorder of brain tumor, systemic infiltrative disease such as histiocytosis, amyoidosis and vasculitis, leukemia, and other autoimmune diseases. But there has been reported only 3 cases of systemic lupus erythematosus (SLE) associated with central diabetes insipidus. The exact pathophysiologic process of pituitary gland involvement in SLE has been unknown, although there are some evidence that vascular impairment and autoantibodies to pituitary gland may be contributory factors. Here, we report a case of central diabetes insipidus complicated by neuropsychiatric systemic lupus erythematosus.
Autoantibodies
;
Autoimmune Diseases
;
Brain Neoplasms
;
Diabetes Insipidus, Neurogenic*
;
Histiocytosis
;
Humans
;
Leukemia
;
Lupus Erythematosus, Systemic*
;
Lupus Vasculitis, Central Nervous System
;
Pituitary Gland
;
Vasculitis
;
Vasopressins
8.Prevalence of Chronic Complications in Korean Patients with Type 2 Diabetes Mellitus Based on the Korean National Diabetes Program.
Sang Youl RHEE ; Suk CHON ; Mi Kwang KWON ; Ie Byung PARK ; Kyu Jeung AHN ; In Ju KIM ; Sung Hoon KIM ; Hyoung Woo LEE ; Kyung Soo KOH ; Doo Man KIM ; Sei Hyun BAIK ; Kwan Woo LEE ; Moon Suk NAM ; Yong Soo PARK ; Jeong taek WOO ; Young Seol KIM
Diabetes & Metabolism Journal 2011;35(5):504-512
BACKGROUND: The Korean National Diabetes Program (KNDP) cohort study is performing an ongoing large-scale prospective multicenter investigation to discover the pathogenesis of type 2 diabetes in Korean patients. This study was performed to examine the prevalence of chronic complications in patients with type 2 diabetes among those registered in the KNDP cohort within the past 4 years. METHODS: This study was performed between June 2006 and September 2009 at 13 university hospitals and included 4,265 KNDP cohort participants. Among the participants, the crude prevalence of microvascular and macrovascular diseases of those checked for diabetes-related complications was determined, and the adjusted standard prevalence and standardization of the general population prevalence ratio (SPR) was estimated based on the 2005 Korean National Health and Nutrition Examination Survey (KNHANES) population demographics. RESULTS: Among the KNDP registrants, 43.2% had hypertension, 34.8% had dyslipidemia, 10.8% had macrovascular disease, and 16.7% had microvascular disease. The SPR of the KNDP registrants was significantly higher than that of the KNHANES subjects after adjusting for demographics in the KNHANES 2005 population. However, with the exception of cardiovascular disease in females, the standardized prevalence for the most complicated items in the survey was significantly higher than that in the KNHANES subjects. CONCLUSION: The prevalence of macrovascular disease and peripheral vascular disease were significantly higher in Korean patients with type 2 diabetes than in the normal population. However, no significant difference was noted in the prevalence of cardiovascular disease in females.
Cardiovascular Diseases
;
Cerebrovascular Disorders
;
Cohort Studies
;
Coronary Disease
;
Demography
;
Diabetes Complications
;
Diabetes Mellitus, Type 2
;
Diabetic Retinopathy
;
Dyslipidemias
;
Female
;
Hospitals, University
;
Humans
;
Hypertension
;
Korea
;
Nutrition Surveys
;
Peripheral Vascular Diseases
;
Prevalence
;
Prospective Studies
9.Independent beneficial effects of aged garlic extract intake with regular exercise on cardiovascular risk in postmenopausal women.
Dae Yun SEO ; Sung Ryul LEE ; Hyoung Kyu KIM ; Yeong Ho BAEK ; Yi Sub KWAK ; Tae Hee KO ; Nari KIM ; Byoung Doo RHEE ; Kyoung Soo KO ; Byung Joo PARK ; Jin HAN
Nutrition Research and Practice 2012;6(3):226-231
The purpose of the study was to assess the effects of a 12 weeks aged garlic extract (AGE) regimen with regular exercise on cardiovascular disease (CVD) risk in postmenopausal women. A total of 30 postmenopausal women (54.4 +/- 5.4 years) were randomly divided into the following four groups: Placebo (Placebo; n = 6), AGE intake (AGEI; n = 8), exercise and placebo (Ex + Placebo; n = 8), exercise and AGE (Ex + AGE; n = 8) groups. The AGE group consume 80 mg per day, and exercise groups performed moderate exercise (aerobic and resistance) three times per week. After 12 weeks of treatment, body composition, lipid profile, and CVD risk factors were analyzed. Body weight was significantly decreased in AGEI, Ex + Placebo, and Ex + AGE groups compared to baseline. Body fat % was significantly decreased in the AGEI and Ex + Placebo groups. Body mass index (BMI) was significantly decreased in the AGEI, Ex + Placebo, and Ex + AGE groups. Fat-free mass was significantly decreased in the AGEI group. Total cholesterol (TC) was significantly lower in the Ex + Placebo compared to the Placebo group. AGE supplementation or exercise effectively reduced low-density lipoprotein (LDL-C). Triglyceride (TG) was significantly increased in the AGEI group. Malondialdehyde (MDA) levels were significantly decreased in the AGEI, Ex + Placebo, and Ex + AGE compared to the placebo group. AGE supplementation reduced homocysteine levels regardless of whether the women also exercised. The present results suggest that AGE supplementation reduces cardiovascular risk factors independently of exercise in postmenopausal women.
Adipose Tissue
;
Aged
;
Body Composition
;
Body Mass Index
;
Body Weight
;
Cardiovascular Diseases
;
Cholesterol
;
Female
;
Garlic
;
Homocysteine
;
Humans
;
Lipoproteins
;
Malondialdehyde
;
Risk Factors
10.Erratum: ACKNOWLEDGMENTS.
Sang Youl RHEE ; Suk CHON ; Mi Kwang KWON ; Ie Byung PARK ; Kyu Jeung AHN ; In Ju KIM ; Sung Hoon KIM ; Hyoung Woo LEE ; Kyung Soo KOH ; Doo Man KIM ; Sei Hyun BAIK ; Kwan Woo LEE ; Moon Suk NAM ; Yong Soo PARK ; Jeong taek WOO ; Young Seol KIM
Diabetes & Metabolism Journal 2011;35(6):643-643
No abstract available.